In the last trading session, 0.21 million shares of the Calidi Biotherapeutics Inc (AMEX:CLDI) were traded, and its beta was 1.15. Most recently the company’s share price was $0.41, and it changed around $0.0 or -0.87% from the last close, which brings the market valuation of the company to $13.05M. CLDI currently trades at a discount to its 52-week high of $4.90, offering almost -1095.12% off that amount. The share price’s 52-week low was $0.35, which indicates that the current value has risen by an impressive 14.63% since then.
Calidi Biotherapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CLDI as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Instantly CLDI has showed a red trend with a performance of -0.87% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4600 on recent trading dayincreased the stock’s daily price by 10.87%. The company’s shares are currently down -64.31% year-to-date, but still up 0.10% over the last five days. On the other hand, Calidi Biotherapeutics Inc (AMEX:CLDI) is -17.47% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $5.5, which translates to bulls needing to increase their stock price by 92.55% from its current value. Analyst projections state that CLDI is forecast to be at a low of $2 and a high of $9.
Calidi Biotherapeutics Inc earnings are expected to increase by 84.85% in 2025, but the outlook is positive 53.95% per year for the next five years.
CLDI Dividends
Calidi Biotherapeutics Inc’s next quarterly earnings report is expected to be released in June.
CPR INVESTMENTS INC., with 1.0511% or 0.56 million shares worth $0.11 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 143.46 shares worth $58875.0, making up 0.45% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 61.37 shares worth around $25187.0, which represents about 0.19% of the total shares outstanding.
